The Saudi Food and Drug Authority has referred the representative of a commercial establishment in Riyadh to the Public Prosecution after he was found to be involved in the sale of a counterfeit pharmaceutical product.
The act is a direct violation of the Pharmaceutical and Herbal Establishments and Products Law in the Kingdom, which mandates a penalty of up to 10 years’ imprisonment and a fine of SR10 million ($2.6 million), the Saudi Press Agency reported.
The SFDA highlighted the importance of strictly adhering to the laws and regulations put in place to ensure the safety and quality of products circulating in the Saudi market.
The authority said that violations pose a great risk to the health and safety of consumers, warranting the enforcement of legal penalties against offenders.
The SFDA also requested the public’s cooperation by reporting any observable violations in establishments under its supervision to the toll-free line 19999, in an effort to strengthen oversight and safeguard public health.
